Outlook · Capital

Investors from outside Europe supply 81% of AI-for-science scale-up capital in Europe

Source of VC invested in European AI-for-science companies since 2020, by investor origin and round stage

53%29%14%5%Early stage$0–15M rounds37%26%33%5%Breakout stage$15–100M rounds13%6%59%22%Scale-up stage$100M+ roundsDomestic-nationalIntra-EuropeanUSARest of world
23

Source: Dealroom.co, 9 November 2026. VC rounds since 2020; founding or HQ in Europe. Each round split equally between its investors, by investor HQ. $5.0B with no investor recorded left out, mostly Isomorphic Labs’ 2026 Series C.

ChemAI Dealroom.co